Recell system (AVRL0101)

Active Purchase Order Awarded Last action

Contract number
W81K0023P0232
Awardee
Awarding agency
Obligated
$869,200

Award facts

Opportunity
Contract value 76% obligated
  • $1,007,200.00 Current, with exercised options
  • $1,145,200.00 Potential, with all options
Completion date 62% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Funding Only Action P00012 $138,000
Other Administrative Action P00011 -$138,000
Exercise an Option P00010 $138,000
Funding Only Action P00009 $138,000
Funding Only Action P00008 · The purpose of this modification is to increase quantities by adding clins 1003 and 1004 $96,600
Exercise an Option P00007 $0
Funding Only Action P00006 $138,000
Other Administrative Action P00005 · Recell go system (AVRL0103) $0
Funding Only Action P00004 $138,000
Funding Only Action P00003 · Increase quantities on clins 0001 and 0002. $82,600
Exercise an Option P00002 $0
Funding Only Action P00001 $138,000
Original award $0
Show all 15

About this award

The Defense Health Agency awarded a firm fixed-price purchase order modification to Avita Medical Americas, LLC on September 14, 2023, with a ceiling value of $1,145,200.00 for RECELL Autologous Cell Harvesting System devices (AVRL0101). No set-aside was used. The modification increases quantities by adding CLINs 1003 and 1004, and performance is at Fort Sam Houston, Texas, with an ultimate completion date of September 30, 2028. The requirement originated from a sole-source Special Notice posted August 10, 2023 by the Medical Readiness Contracting Office - West, which set an August 17, 2023 response deadline and required FDA and TJC compliance under NAICS 339112.

Quick answers

Who was awarded contract W81K0023P0232?

W81K0023P0232 was awarded to Avita Medical Americas, LLC by Medical Command (Department of the Army) on September 14, 2023.

How much is contract W81K0023P0232 worth?

The government has obligated $869,200 on W81K0023P0232. Its current value, with exercised options, is $1,007,200. Its potential value, with all options, is $1,145,200.

Which agency awarded contract W81K0023P0232?

Medical Command (Department of the Army) awarded W81K0023P0232, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0023P0232 competed?

The extent of competition for W81K0023P0232 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award